Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Apogee Therapeutics, Inc. (APGE)

Weekly Buzz: AZN, JNJ Get FDA Nod; LLY To Acquire Curevo; APGE Advances Zumilokibart 5/29/2026 10:39:40 AM

Wedbush Reaffirms Apogee Therapeutics At Outperform; Lifts Price Target To $135 5/28/2026 4:33:48 AM

Morning Market Movers: FGL, VRRM, MNTS, AIMD See Big Swings 5/27/2026 7:52:09 AM

Apogee Therapeutics Secures Up To $1.3 Bln Financing From Blackstone For Zumilokibart 5/27/2026 7:22:18 AM

Apogee Therapeutics Stock Tumbles 11% Despite Positive Phase 2 Results For Zumilokibart In AD 5/27/2026 7:03:10 AM

Apogee Therapeutics Secures Up To $1.3 Bln Strategic Financing From Blackstone To Advance Zumilokibart Development 5/27/2026 6:42:02 AM

Apogee Reports Positive Phase 2 Results For Zumilokibart In Moderate-to-Severe Atopic Dermatitis; Stock Drops 5/27/2026 6:40:24 AM

Wedbush Reaffirms BCAX, APGE, CATX At Outperform; Highlights Key Milestones 5/13/2026 9:25:30 AM

Apogee Therapeutics Shares Jump 14% After $350 Mln Public Offering Pricing 3/25/2026 12:15:52 PM

Apogee Therapeutics Prices $350 Mln Public Offering Of Common Stock 3/24/2026 10:05:33 PM

Apogee Therapeutics Shares Fall 7% After Stock Offering Announcement 3/24/2026 11:18:59 AM

Apogee Therapeutics Announces $300 Mln Public Offering 3/24/2026 2:30:00 AM

Apogee Therapeutics Announces $300 Mln Public Offering Of Shares 3/24/2026 1:39:30 AM

Apogee Therapeutics Shares Jump 19% On Positive Phase 2 Data Of Atopic Dermatitis Drug 3/23/2026 11:25:13 AM

Morning Market Movers: UGRO, WSHP, QVCGA, APGE See Big Swings 3/23/2026 8:43:49 AM

Apogee's Year-Long Study Shows Deepening Skin Improvements With Just Two To Four Doses A Year 3/23/2026 7:43:55 AM

Apogee To Present 52-Week Phase 2 Data For Zumilokibart In Atopic Dermatitis, Today 3/23/2026 5:43:55 AM

Older Articles

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap